跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pamidol 370 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pamidol 370
Approved
STANDARD
Pamidol 370
Unique Pharmaceutical Laboratories ( A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5244fbb94d6b3019
Company
Unique Pharmaceutical Laboratories ( A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
Type
Standard
Approval Details
Approval Id
5244fbb94d6b3019
Drug Approval Philippines Name
Pamidol 370
Product Name
Pamidol 370
Registration Number
DRP-8262
Brand Name
Pamidol 370
Generic Name
Iodine (as Iopamidol)
Dosage Form
Solution For Injection
Dosage Strength
370mg/Ml (Equi. To 755.3mg/Ml Iopamidol)
Manufacturer
Unique Pharmaceutical Laboratories ( A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
Importer
S.M.H.P. Marketing & Consultancy
Distributor
S.M.H.P. Marketing & Consultancy
Issuance Date
29 June 2024
Expiry Date
10 July 2029
Pharmacologic Category
Water-soluble, nephrotropic, low osmolar X-ray contrast media
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5244fbb94d6b3019
Type
Standard
Back to Philippines FDA Approvals